Title: |
Expert consensus of immunemodulatory therapy of chronic obstructive pulmonary disease |
Edition: |
Original |
Classification: |
Experts consensus |
Field: |
Treatment |
Countries and regions: |
China |
Guidelines users: |
Chinese pulmonary and critical care medicine specialists and community doctors |
Evidence classification method: |
Evidence grading and recommendation intensity system of Oxford evidence-based medicine center |
Development unit: |
Peking University Third Hospital |
Registration time: |
2022-05-13 |
Registration number: |
IPGRP-2022CN267 |
Purpose of the guideline: |
Promote th clinical practice of immunomodulatory therapy in Chinese COPD patients. |